2015, Clinical Trials and Data - Medical Cannabis Brief

Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.

Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. Ehave, Inc.

Clinical Trials

Clinical Trials Research and Development Data Patients

Medical cannabis studies offer hope to opioid users

Healer

MARCH 26, 2021

Since 2015, the National Institutes of Health’s National Institute on Drug Abuse has funded research surrounding the therapeutic benefits of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of pain as an alternative to opioids, addiction and other disorders. In 2015, the institute devoted $21 million to the research.

Chronic Pain

Chronic Pain Clinical Trials Treatment Patients

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

JULY 6, 2021

We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology.

Research and Development

Research and Development Wellness and Beauty Clinical Trials Therapy

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

AUGUST 16, 2018

Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.

Strains

Strains Cannabinoids Research and Development Indica

How medical marijuana could help you find the ‘new you’ in the New Year

Canna Care Docs

DECEMBER 16, 2020

The evidence of its effectiveness is clear, as clinical trials have shown a significant reduction in pain for patients suffering with neuropathic pain from multiple sclerosis, pain from rheumatoid arthritis, cancer pain, HIV or complex regional pain syndrome, headaches and menstrual pain, among other potential uses. Chronic pain.

Chronic Pain

Chronic Pain Marijuana Clinical Trials Epilepsy

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials

Clinical Trials Therapy Research and Development DEA

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials

Clinical Trials Medicine Research and Development Compliance

Singapore’s Minister for Law & Home Affairs Says Medicinal Cannabis Companies Are Just In It For The Money

Cannabis Law Report

FEBRUARY 15, 2019

The Institute of Mental Health (IMH) did a review of 500 articles between 1964 and 2015 on the effects of cannabis. There is even published research, derived from clinical trials, on the potential uses of cannabinoids to manage seizures and epilepsy, cited the ministries. He said, “The research, in our view, is quite clear.

Medicine

Medicine Pharmaceutical Law Cannabinoids

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015.

Extraction

Extraction Pharmaceutical CBD Epilepsy

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. CBD for CTE.

THC

THC CBD Cannabinoids Research and Development

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

JUNE 10, 2021

Studies of crash or driving data suggest that, although permissive marijuana policies are associated with higher prevalence of tetrahydrocannabinol (THC) presence among drivers [ 1 , 2 ], there is mixed evidence that these policies are associated with motor vehicle crashes [ 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. never vs. at least once). (2)

Policy

Policy Safety Marijuana Data

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Researchers in Israel, Sweden, Estonia, and the USA have investigated media discourses about medicinal cannabis (Sznitman and Lewis 2015 ; Lewis et al. 2015 ; Kaiser 2011 ; Mortensen et al. Data collection.

Research and Development

Research and Development Medicine Access Media

Green Relief - Untitled Article

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. CBD for CTE.

Research and Development

Research and Development Cannabinoids Therapy CBD

Mixing weed and alcohol: the good, the bad and the ugly

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. Drink or smoke first: Does ‘weed before beer everything clear’ really matter? arguing while drinking.

Research and Development

Research and Development Clinical Trials Edibles THC

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety

Safety CBD Clinical Trials Oil

July 18: Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review

Cannabis Law Report

JULY 21, 2022

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. ” The complaint alleges that MAPS improperly blended data from small study sites that used different methodologies to produce favourable results.

Safety

Safety Patients Clinical Trials Data

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. In 2015, Cannabase.io Since founding Eleusis in 2013, Shlomi has overseen the company’s corporate and clinical development efforts.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Medical Cannabis Brief

Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.

Medical cannabis studies offer hope to opioid users

Trending Sources

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Using Cannabis for ALS: Benefits, Research and Best Strains

How medical marijuana could help you find the ‘new you’ in the New Year

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Jones Day: The life sciences regulatory regime in Australia

Singapore’s Minister for Law & Home Affairs Says Medicinal Cannabis Companies Are Just In It For The Money

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

NO BRAINER: CBD AND THC FOR HEAD INJURIES

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Green Relief - Untitled Article

Mixing weed and alcohol: the good, the bad and the ugly

ElleVet Sciences Publishes Safety Study On CBD For Animals

July 18: Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected